Avanafil (Spedra)

What is AVANAFIL (SPEDRA)?

AVANAFIL (SPEDRA) is a modern pharmaceutical drug from the group of phosphodiesterase type 5 inhibitors, designed for the correction of erectile dysfunction in adult men. The active substance ensures improved blood supply to the cavernous bodies of the penis under the condition of sexual stimulation, which helps to achieve and maintain an erection sufficient for sexual intercourse. The drug is available in the form of tablets for oral use in various dosages, allowing the doctor to choose the optimal therapy regimen. The pharmacological group combines agents that selectively affect the PDE5 enzyme and do not replace natural sexual arousal. Before starting use, a consultation with a doctor is mandatory, as the body's reaction is always individual.

AVANAFIL (SPEDRA) is characterized by a relatively rapid onset of action compared to some other representatives of the same group, which is important for patients who value flexibility in planning intimate closeness. The tablets are convenient to use and do not require complex preparation conditions. The manufacturer supplies the drug in blisters with protection against moisture and light, which preserves the stability of the active substance throughout the specified shelf life. Clinical data confirm the effectiveness of the agent with proper dose selection and adherence to recommendations. Self-treatment is unacceptable, as only a specialist can assess indications, concomitant diseases, and potential risks.

The use of AVANAFIL (SPEDRA) is considered part of a comprehensive approach to the treatment of erectile dysfunction, which may include lifestyle modification, control of chronic diseases, and psychological support. The drug does not increase libido by itself and does not protect against sexually transmitted infections. It is important for patients to understand the mechanism of action and have realistic expectations from the therapy. The individual response depends on age, concomitant pathology, use of other medicines, and lifestyle. Any doubts regarding the advisability of use should be discussed with a doctor before the first dose.

What is AVANAFIL (SPEDRA) prescribed for?

The main indication for the use of AVANAFIL (SPEDRA) is erectile dysfunction — the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual intercourse. This condition may be associated with vascular disorders, neurological factors, hormonal changes, psychogenic causes, or a combination of several factors. The drug helps restore the physiological mechanism of filling the cavernous bodies with blood during sexual arousal. The doctor assesses the severity of symptoms, the duration of the problem, and the impact on the quality of life before prescribing. Therapy is aimed at improving sexual function rather than treating the underlying disease that might have caused the disorder.

AVANAFIL (SPEDRA) may be recommended for men with vascular risk factors, particularly in arterial hypertension, diabetes mellitus, or atherosclerosis, if the doctor considers the PDE5 inhibitor safe and appropriate. In such cases, it is important to pre-check the cardiovascular status, as sexual activity itself places a load on the heart. The drug does not replace the basic treatment of chronic diseases and does not cancel the need for glucose, blood pressure, or lipid control. Patients with a psychogenic component of erectile dysfunction may also benefit, but additional work with a psychologist or sexologist is often required. The decision to prescribe is always individual.

The drug is not intended for women, adolescents, and men without diagnosed erectile dysfunction. It is not used to enhance "athletic" performance or as a stimulant without medical indications. The doctor may combine the recommendation for AVANAFIL (SPEDRA) with advice on smoking cessation, weight normalization, and moderate physical activity. The effectiveness is highest under conditions of real sexual stimulation and compliance with the instructions. If there is no effect after several attempts, a repeat consultation is needed to review the dose or diagnosis.

Composition and active components of AVANAFIL (SPEDRA)

The active substance of AVANAFIL (SPEDRA) is avanafil — a selective phosphodiesterase type 5 inhibitor. Blocking PDE5 prevents the breakdown of cyclic guanosine monophosphate in the smooth muscles of the penile vessels, which promotes their relaxation and increased blood flow. This mechanism is realized only in the presence of nitric oxide, which is released during sexual excitement, so the drug does not cause spontaneous erection without stimulation. The dosage of the active substance in the tablet determines the strength and duration of the effect within the therapeutic window. Auxiliary components ensure tablet stability, dissolution, and absorption in the gastrointestinal tract.

Among the excipients, fillers, binders, disintegrants, and coating components are usually present, the composition of which is specified in the instructions of the specific manufacturer. They do not have an independent pharmacological effect on erection, but are important for the bioavailability of avanafil. The drug is contraindicated in patients with an allergy to any component of the tablet. The mechanism of action of avanafil differs by the speed of onset of the effect in a portion of patients, which is related to the pharmacokinetic properties of the molecule. Understanding the composition helps to avoid incompatibility with other agents and correctly assess risks.

AVANAFIL (SPEDRA) does not contain hormones and does not directly affect testosterone levels. Its action is localized mainly in the vascular bed of the penis, although PDE5 is also present in other tissues, which explains certain side effects. Metabolism occurs mainly in the liver with the participation of the cytochrome system, so liver status and concomitant medications are important. Individual sensitivity to the active substance varies, so the same dose can give different results in different men. All questions regarding the composition and mechanism should be clarified with a doctor or pharmacist.

Dosage of AVANAFIL (SPEDRA)

The recommended starting dose of AVANAFIL (SPEDRA) for most adult men is determined by the doctor individually and often represents an average therapeutic level with subsequent adjustment. The tablet is taken as needed approximately 15–30 minutes before expected sexual activity, guided by the instructions and the patient's feelings. The maximum frequency of administration usually does not exceed one dose per day to avoid accumulation and increased side reactions. The duration of the course is not fixed: the drug is used situationally, rather than as a daily therapy without specific indications. Dose adjustment depends on efficacy, tolerability, age, and liver and kidney function.

In elderly men or those with impaired liver function, the doctor may start with a lower dose and monitor the response more closely. With insufficient effect and good tolerability, the dose is increased within the permitted range, not exceeding the maximum specified in the official instructions. A dose reduction is required if pronounced side effects appear or with simultaneous administration of certain inhibitors of metabolic enzymes. It is dangerous to change the number of tablets on your own. Regular feedback with the doctor helps find the optimal ratio of benefit and risk.

AVANAFIL (SPEDRA) is not intended for continuous daily use "just in case" without medical justification. If erectile dysfunction progresses or new cardiovascular symptoms appear, the regimen is reviewed. It is important for patients to record how long it takes for the effect to occur and how long it lasts so that the doctor can adjust the recommendations. Exceeding the dose does not guarantee a stronger erection, but instead increases the likelihood of headache, flushing, drop in blood pressure, and other reactions. Any changes in dosage are agreed upon only with a specialist.

How to take AVANAFIL (SPEDRA) correctly?

The AVANAFIL (SPEDRA) tablet is swallowed whole with a sufficient amount of water, without chewing or crushing, unless otherwise specified by the doctor. Administration is possible regardless of food intake, but fatty and heavy food can slow down absorption and delay the onset of action. It is optimal to plan the intake so that sexual stimulation coincides with the expected window of the drug's effectiveness. Alcohol in large quantities worsens erection and increases the risk of dizziness and drop in blood pressure, so it is better to limit it. Before the first use, you should carefully read the instructions and discuss all concomitant medications with your doctor.

If a dose is missed and sexual activity is no longer planned, the next dose is not doubled — the drug is used only as needed. It is important not to take AVANAFIL (SPEDRA) more than once every 24 hours. Patients with unstable arterial pressure or recent cardiovascular events require special caution and a prior examination. The drug does not replace a condom and does not protect against infections. Store the tablets out of reach of children and do not use the product from a damaged package.

During therapy, it is worth monitoring your well-being: a sudden deterioration of vision, hearing, chest pain, or a prolonged painful erection requires immediate medical attention. Combination with other erection stimulants without a doctor's prescription is prohibited. The body's individual reaction may differ, so the first intake is preferably carried out in conditions where there is an opportunity to calmly assess tolerability. Consultation with a doctor before starting and when the health state changes remains a mandatory condition for the safe use of AVANAFIL (SPEDRA).

Side effects of AVANAFIL (SPEDRA)

The most common side effects of AVANAFIL (SPEDRA) include headache, hot flushes to the face, nasal congestion, and dyspeptic phenomena. These reactions are usually mild or moderate and pass on their own as the drug is eliminated. They are associated with the expansion of blood vessels not only in the penis but also in other areas. In some patients, dizziness, muscle pain, or back pain are possible. If symptoms are pronounced or prolonged, the doctor should be informed to adjust the dose or change the approach.

Uncommon and rare reactions include visual impairment, changes in color perception, sensation of palpitations, drop in blood pressure, rash, and allergic manifestations. Priapism — an erection lasting more than four hours that requires urgent medical attention due to the risk of tissue damage — is described very rarely. Sudden loss of vision or hearing also requires immediate medical attention. Patients with previous episodes of similar conditions should discuss the risks especially carefully. Any unusual reaction after taking AVANAFIL (SPEDRA) is a reason for consultation.

The likelihood of side effects increases when the dose is exceeded, when combined with incompatible medicines or alcohol, and in severe concomitant diseases. The doctor assesses the ratio of benefit and risk individually. Most men tolerate the drug satisfactorily when recommendations are followed. Do not ignore heart symptoms during sexual activity — chest pain, shortness of breath, or strong palpitations require stopping activity and examination by a specialist. Individual sensitivity is always different, so the experience of other patients cannot be mechanically transferred to oneself.

Contraindications of AVANAFIL (SPEDRA)

Absolute contraindications to AVANAFIL (SPEDRA) are hypersensitivity to avanafil or any component of the tablet, simultaneous administration of nitrates or nitric oxide donors, as well as severe forms of cardiovascular pathology in which sexual activity is undesirable. The drug is not used in case of recently suffered myocardial infarction, stroke, life-threatening arrhythmias, unstable angina, and uncontrolled arterial hypertension or hypotension. Severe hepatic impairment and certain hereditary degenerative retinal diseases also limit use. The decision to prohibit use is made by the doctor after assessing the medical history.

Relative contraindications include moderate liver and kidney function impairment, anatomical deformations of the penis, predisposition to priapism, bleeding, and active peptic ulcer disease. In such cases, use is possible only after careful evaluation and often in a reduced dose. AVANAFIL (SPEDRA) is not intended for women, including during pregnancy and lactation, and is not used in childhood and adolescence. For elderly patients, the drug may be prescribed with caution, taking into account polypragmasy and vascular risks. An independent decision to take the drug in the presence of chronic diseases is unacceptable.

Before starting therapy, it is necessary to inform the doctor about all medicines, dietary supplements, and herbal remedies that are taken constantly or periodically. Special attention is paid to the heart, blood pressure, vision, and past surgeries. If the state of health has changed since the previous consultation, a new examination is needed. AVANAFIL (SPEDRA) is not an emergency aid for acute conditions. Compliance with contraindications significantly reduces the likelihood of serious complications and makes therapy more predictable.

Interaction of AVANAFIL (SPEDRA) with other drugs and alcohol

AVANAFIL (SPEDRA) is categorically incompatible with nitrates and agents that release nitric oxide due to the risk of a sharp drop in blood pressure. Caution is required when combining with alpha-blockers, certain antihypertensive drugs, strong CYP3A4 inhibitors or inducers, as well as with other agents for the treatment of erectile dysfunction. Antibiotics, antifungal, and antiviral medicines of a certain class can change the concentration of avanafil in the blood. The doctor adjusts the dose or prohibits the combination depending on the specific list of drugs. The patient is obliged to provide a complete list of all agents taken.

Alcohol in large doses enhances vasodilation, increases the likelihood of dizziness, tachycardia, and orthostatic hypotension, and also by itself worsens the quality of erection. Moderate consumption does not cancel the need for caution. During the action of AVANAFIL (SPEDRA), mild dizziness is possible, so driving a car and working with mechanisms require an assessment of well-being. If attention or coordination disorders occur, driving should be avoided. Any doubts regarding drug compatibility and lifestyle are discussed with the doctor before starting use.

Where to buy AVANAFIL (SPEDRA) in Ukraine

AVANAFIL (SPEDRA) is available in pharmacy chains in Ukraine and through licensed online pharmacies if a prescription is required by current legislation and the dispensing category. Before buying, you should check the expiration date, the integrity of the packaging, and the presence of instructions in Ukrainian. Store the tablets in a dry place at the temperature specified by the manufacturer, away from direct light and children. Delivery from online pharmacies is carried out in accordance with the rules of the carrier and the conditions of storage of thermolabile and conventional dosage forms. Do not buy the drug from doubtful sources without a guarantee of quality and origin.

Before using AVANAFIL (SPEDRA), be sure to consult a doctor: only a specialist will determine the feasibility, dose, and safety, taking into account your health status. The body's reaction to the drug is individual, so effectiveness and tolerability may differ. This description is for informational purposes and does not replace the official instructions or personal medical consultation. If any alarming symptoms appear, seek medical help immediately. A responsible attitude to treatment helps to achieve the expected result with minimal risks.